Related Experiment Video
Updated: Sep 24, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Raf kinase inhibitory protein reduces bradykinin receptor desensitization
Samuel B Chivers1, Allison Doyle Brackley2, Nathaniel A Jeske1,2,3
1Departments of Oral & Maxillofacial Surgery, University of Texas Health San Antonio, San Antonio, Texas, USA.
Abstract:
Inflammatory hyperalgesia represents a nociceptive phenotype that can become persistent in nature through dynamic protein modifications. However, a large gap in knowledge exists concerning how the integration of intracellular signaling molecules coordinates a persistent inflammatory phenotype. Herein, we demonstrate that Raf Kinase Anchoring Protein (RKIP) interrupts a vital canonical desensitization pathway to maintain bradykinin (BK) receptor activation in primary afferent neurons. Biochemical analyses of primary neuronal cultures indicate bradykinin-stimulated PKC phosphorylation of RKIP at Ser153. Furthermore, BK exposure increases G-protein Receptor Kinase 2 (GRK2) binding to RKIP, inhibiting pharmacological desensitization of the BK receptor. Additional studies found that molecular RKIP down-regulation increases BK receptor desensitization in real-time imaging of primary afferent neurons, identifying a key pathway integrator in the desensitization process that controls multiple GRK2-sensitive G-protein coupled receptors. Therefore, RKIP serves as an integral scaffolding protein that inhibits BK receptor desensitization.
Insights
Raf Kinase Anchoring Protein (RKIP) prevents bradykinin receptor desensitization in neurons. This protein scaffolding inhibits inflammatory hyperalgesia by maintaining receptor activation, offering new therapeutic targets.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Inflammatory hyperalgesia can persist due to protein modifications.
- Intracellular signaling's role in persistent inflammatory phenotypes is not fully understood.
Purpose of the Study:
- To investigate the role of Raf Kinase Anchoring Protein (RKIP) in bradykinin (BK) receptor desensitization.
- To elucidate how RKIP integrates intracellular signaling to regulate inflammatory pain pathways.
Main Methods:
- Biochemical analyses of primary neuronal cultures.
- Studying bradykinin-stimulated phosphorylation of RKIP by PKC.
- Assessing GRK2 binding to RKIP upon BK exposure.
- Real-time imaging to observe BK receptor desensitization with RKIP down-regulation.
Main Results:
- Bradykinin stimulates PKC phosphorylation of RKIP at Ser153.
- BK exposure increases GRK2 binding to RKIP, inhibiting BK receptor desensitization.
- RKIP down-regulation enhances BK receptor desensitization in primary afferent neurons.
Conclusions:
- RKIP acts as a scaffolding protein that inhibits BK receptor desensitization.
- RKIP interrupts a key pathway for canonical desensitization, maintaining BK receptor activation.
- RKIP is a crucial pathway integrator controlling multiple GRK2-sensitive G-protein coupled receptors.
Related Concept Videos
GPCR Desensitization
The JAK-STAT Signaling Pathway
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Desensitization and Tachyphylaxis

